Stocktitan

Published October 15, 2026

NRx Pharmaceuticals: FDA seeks minor ketamine label changes | NRXP Stock News

Read the full story at Stocktitan

Final manufacturing validation runs are underway to meet launch requirements; FDA's GDUFA goal date for the application is Nov. 10, 2026.